Mesalamine Capsule, Extended Release
Product Images NDC 0093-9224

2 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0093-9224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Image 02)

Description (Image 02)
Chemical structure of mesalamine, showing a benzene ring with amino, hydroxyl, and carboxyl functional groups attached.*
FDA Label Image

Pdp (Image 01)

Pdp (Image 01)
Label for Mesalamine Extended-Release Capsules with strength 0.375 g, distributed by Teva Pharmaceuticals USA, Inc. The label indicates the product NDC 0093-9224-89 and that the package contains 120 capsules. Storage instructions and warnings such as phenylketonurics containing phenylalanine are included, along with barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.